Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-08 07:06 am Purchase | 2023-11-06 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 95,561,160 13.630% | 2,188,575 (+2.34%) | Filing History |
| 2023-11-06 07:30 am Purchase | 2023-11-03 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 93,372,585 13.320% | 1,081,380 (+1.17%) | Filing History |
| 2023-11-02 07:30 am Purchase | 2023-10-31 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 92,291,205 13.250% | 92,130 (+0.10%) | Filing History |
| 2023-10-30 6:02 pm Purchase | 2023-10-27 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 92,199,075 13.150% | 2,168,475 (+2.41%) | Filing History |
| 2023-08-10 4:42 pm Sale | 2023-07-31 | 13G | Mereo BioPharma Group plc MREO | BAKER BROS. ADVISORS LP | 14,604,391 2.200% | -54,754,968 (-78.94%) | Filing History |
| 2023-07-26 4:31 pm Purchase | 2023-07-24 | 13G | Mereo BioPharma Group plc MREO | Soleus Private Equity Fund III L.P. | 48,387,095 7.500% | 48,387,095 (New Position) | Filing History |
| 2023-06-16 08:00 am Purchase | 2023-06-14 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 90,030,600 14.410% | 6,250,000 (+7.46%) | Filing History |
| 2023-02-14 4:40 pm Purchase | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | ORBIMED ADVISORS LLC | 10,378,591 5.920% | 4,315,246 (+71.17%) | Filing History |
| 2023-02-14 4:03 pm Sale | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Point72 Asset Management, L.P. | 22 0.100% | -10,609,978 (-100.00%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | BAKER BROS. ADVISORS LP | 69,359,359 9.990% | 4,441,758 (+6.84%) | Filing History |
| 2023-02-14 2:55 pm Purchase | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 31,224,485 5.340% | 25,638,864 (+459.02%) | Filing History |
| 2023-02-13 5:48 pm Sale | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX, LLC | 3,761,947 3.100% | -5,647,104 (-60.02%) | Filing History |
| 2023-02-13 1:21 pm Sale | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | SUVRETTA CAPITAL MANAGEMENT LLC | 36,822,190 5.900% | -8,888,145 (-19.44%) | Filing History |
| 2022-10-28 1:17 pm Unchanged | 2022-10-28 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 83,780,600 13.410% | 0 (Unchanged) | Filing History |
| 2022-09-23 4:18 pm Unchanged | 2022-09-15 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 83,780,600 13.410% | 0 (Unchanged) | Filing History |
| 2022-08-23 6:31 pm Purchase | 2022-08-19 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 83,780,600 14.320% | 1,507,790 (+1.83%) | Filing History |
| 2022-06-14 10:21 am Purchase | 2022-06-13 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 82,272,810 14.070% | 5,480,185 (+7.14%) | Filing History |
| 2022-06-09 08:00 am Purchase | 2022-06-09 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 76,792,625 13.129% | 1,792,625 (+2.39%) | Filing History |
| 2022-05-26 5:29 pm Purchase | 2022-05-26 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 75,000,000 12.820% | 427,765 (+0.57%) | Filing History |
| 2022-02-15 12:44 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 5,585,621 5.130% | 5,585,621 (New Position) | Filing History |